¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of SABCS(San Antonio Breast Cancer Symposium) 2023 : 2024-02-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of SABCS(San Antonio Breast Cancer Symposium) 2023 : 2024-02-03
±³À°ÀÏÀÚ : 2024-02-03
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿Èú ¼­¿ï

±³À°ÁÖÁ¦ : Best of SABCS(San Antonio Breast Cancer Symposium) 2023

ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ±è¿¹Áö
¿¬¶ôó : 02-735-2857  

À̸ÞÀÏ : meetings@ksmo.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 35ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í "±³¼ö Àü¹®ÀÇ : 50,000¿ø(»çÀü) / 60,000(ÇöÀå)

ÀüÀÓÀÇ,Àü°øÀÇ : 30,000¿ø(»çÀü) / 40,000(ÇöÀå) 

¾÷ü ¹× ±âŸ : 70,000¿ø(»çÀü) / 80,000¿ø(ÇöÀå)"  


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 09:00~09:25 Update of tumor heterogeneity and liquid biopsy in breast cancer ±è°Ç¹Î(¿¬¼¼¾Ïº´¿ø)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 09:25~09:50 Translational insights in immuno-oncology and endocrine resistance äÈñÁ¤(±¹¸³¾Ï¼¾ÅÍ)

Åä·Ð 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 09:50~10:05 Q&A ( )

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 10:15~10:30 Minimizing surgical treatment in early breast cancer : Surgeon ÇѾָ®(¿øÁÖ¼¼ºê¶õ½º)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 10:30~10:45 Optimal approach in early breast cancer : Radiation Oncologist ±èÇØ¿µ(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 10:45~11:10 Invasive lobular carcinoma and update of AI-assisted approaches of breast cancer °íÁö¿ø(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 11:10~11:35 Prevention and management of breast cancer risk ±èÈñÁ¤(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 11:35~12:00 Insights in special populations and toxicity management ±èÇÑÁ¶(¼øõÇâ´ë õ¾Èº´¿ø)

Åä·Ð 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 12:00~12:20 Q&A ( )

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 12:20~13:00 Highlights in SABCS 2023: Ribociclib focused view ½É¼ºÈÆ(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 13:30~13:55 Advances in HR+/HER2- Early breast cancer ±èÁö¿¬(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 13:55~14:20 Advances in HR+/HER2- Metastatic breast cancer ÀÌÁöÀº(¼­¿ï¼º¸ðº´¿ø)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 14:20~14:45 Treatment post-CDK4/6 inhibitor and novel targeted agents ÀÌÀÎÈñ(°æºÏ´ëº´¿ø)

Åä·Ð 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 14:45~15:00 Q&A ( )

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 15:20~15:50 Update for HER2-positive breast cancer ¹ÚÀÎÇý(°í´ë±¸·Îº´¿ø)

±³À°½Ã°£ 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 15:50~16:20 Novel therapeutic approaches of TNBC and low HER2 breast cancer ÀÌ°æÈÆ(¼­¿ï´ëº´¿ø)

Åä·Ð 02¿ù 03ÀÏ ºñ½ºÅ¸È¦ 16:20~16:35 Q&A ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of SABCS(San Antonio Breast Cancer Symposium) 2023 : 2024-02-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Á¦53Â÷ ´ëÇѼҾƽŰæ¹ß´ÞÇൿ¿¬±¸È¸ ÇмúÁý´ãȸ : 2024-02-03
´ÙÀ½±Û Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ ÀΰøÁö´É¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö : 2024-02-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 11 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 17 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 9 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 6 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 8 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 9 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 4 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 2 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 3 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 6 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 6 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 4 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 5 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 4 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 7 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷